The Effect of Belantamab Mafodotin on Primary Myeloma–Stroma Co-Cultures: Asymmetrical Mitochondrial Transfer between Myeloma Cells and Autologous Bone Marrow Stromal Cells

Belantamab mafodotin (belamaf) is an afucosylated monoclonal antibody conjugated to the microtubule disrupter monomethyl auristatin-F (MMAF) that targets B cell maturation antigen (BCMA) on the surface of malignant plasma cells. Belamaf can eliminate myeloma cells (MMs) through several mechanisms. O...

Descripción completa

Detalles Bibliográficos
Autores principales: Matula, Zsolt, Uher, Ferenc, Vályi-Nagy, István, Mikala, Gábor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10048929/
https://www.ncbi.nlm.nih.gov/pubmed/36982377
http://dx.doi.org/10.3390/ijms24065303

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10048929/
https://www.ncbi.nlm.nih.gov/pubmed/36982377
http://dx.doi.org/10.3390/ijms24065303

Ejemplares similares